0001171843-18-006626.txt : 20180919
0001171843-18-006626.hdr.sgml : 20180919
20180919152115
ACCESSION NUMBER: 0001171843-18-006626
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180402
FILED AS OF DATE: 20180919
DATE AS OF CHANGE: 20180919
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Islam Khalid
CENTRAL INDEX KEY: 0001701858
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-12104
FILM NUMBER: 181077705
MAIL ADDRESS:
STREET 1: C/O IMMUNOMEDICS, INC.
STREET 2: 300 THE AMERICAN ROAD
CITY: MORRIS PLAINS
STATE: NJ
ZIP: 07950
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMMUNOMEDICS INC
CENTRAL INDEX KEY: 0000722830
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 611009366
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 300 AMERICAN RD
CITY: MORRIS PLAINS
STATE: NJ
ZIP: 07950
BUSINESS PHONE: 9736058200
MAIL ADDRESS:
STREET 1: 300 AMERICAN ROAD
CITY: MORRIS PLAINS
STATE: NJ
ZIP: 07950
4
1
ownership.xml
X0306
4
2018-04-02
0
0000722830
IMMUNOMEDICS INC
IMMU
0001701858
Islam Khalid
C/O IMMUNOMEDICS, INC
300 THE AMERICAN ROAD
MORRIS PLAINS
NJ
07950
1
0
0
0
Common Stock, $0.01 par value per share
2018-04-02
4
A
0
3849
0
A
3849
D
Stock Options (right to buy)
14.29
2018-04-02
4
A
0
6497
0.0
A
2019-04-02
2025-04-02
Common Stock, par value $0.01 per share
6497
6497
D
Such grants of restricted stock units and stock options were made automatically pursuant to the Issuer's compensation policy for non-employee directors as of the date of the Issuer's 2018 annual meeting of stockholders, which occurred on April 2, 2018.
Includes restricted stock units that represent a contingent right to receive one share of the Issuer's common stock. The restricted stock units shall vest on the first anniversary of the date of grant, subject to the Reporting Person's continued service as a director of the Issuer.
The stock options vest on the first anniversary of the date of grant, subject to the Reporting Person's continued service as a director of the Issuer.
/s/ Khalid Islam
2018-09-18